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Leukemia Inhibitory Factor Promotes Neural Stem Cell
Self-Renewal in the Adult Brain
Sylvian Bauer and Paul H. Patterson
Biology Division, California Institute of Technology, Pasadena, California 91125
Althoughneural stem cells (NSCs) persist in various areas of the adult brain, their contribution to brain repair after injury is very limited.
Treatment with exogenous growth factors can mitigate this limitation, suggesting that the brain environment is normally deficient in
permissive cues and that it may be possible to stimulate the latent regenerative potential of endogenous progenitors with appropriate
signals. We analyzed the effects of overexpressing the cytokine leukemia inhibitory factor (LIF) on adult neurogenesis in the normal
brain. We found that LIF reduces neurogenesis in the olfactory bulb and subventricular zone by acting directly on NSCs. LIF appears to
promote NSC self-renewal, preventing the emergence of more differentiated cell types. This ultimately leads to an expansion of the NSC
pool. Our results have implications for the development of therapeutic strategies for brain repair and suggest that LIF may be useful, in
combination with other factors, in promoting regeneration in the adult brain.
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Introduction
The adult brain contains multipotent neural stem cells (NSCs)
and committed progenitors that participate in brain repair, albeit
to a very limited extent (Magavi et al., 2000; Arvidsson et al., 2002;
Nakatomi et al., 2002). It may be possible to stimulate brain
repair from endogenous precursors in the injured brain by find-
ing conditions that will unleash and channel this dormant
potential.
Many types of injuries to the nervous system are accompanied
by a rapid and transient increased expression of leukemia inhib-
itory factor (LIF) (Banner and Patterson, 1994; Banner et al.,
1997; Jankowsky andPatterson, 1999; Suzuki et al., 2000;Minami
et al., 2002; Bauer et al., 2003; Sriram et al., 2004). In this context,
LIF is known to regulate neuronal phenotype (Rao et al., 1993;
Corness et al., 1996; Sun and Zigmond, 1996; Holmberg and
Patterson, 2006) and coordinate the astrocyte, oligodendrocyte,
microglia, and inflammatory cell responses (Sugiura et al., 2000;
Kerr and Patterson, 2004, 2005; Holmberg and Patterson, 2006).
Importantly, LIF is required for the lesion-induced proliferation
of neuronal progenitors in the regenerating adult olfactory epi-
thelium (Bauer et al., 2003), suggesting that LIF may promote
neurogenesis after other types of injury.
LIF is amember of the cytokine family that signals through the
heterodimeric glycoprotein 130 (gp130)/LIF receptor (LIFR)
complex, which also includes ciliary neurotrophic factor
(CNTF), interleukin (IL)-6, IL-11, OSM (oncostatin M), CT-1
(cardiotrophin-1), and CLC/NNT-1 (cardiotrophin-like cyto-
kine/novel neurotrophin-1) (Heinrich et al., 2003). LIF signaling
activates the Jak (Janus kinase)/STAT (signal transducer and ac-
tivator of transcription) and MAP (mitogen-activated protein)
kinase pathways, which promote astrogliogenesis in vitro (Bonni
et al., 1997;Molne et al., 2000; Viti et al., 2003; Chang et al., 2004;
Barnabe-Heider et al., 2005; He et al., 2005). In addition, LIF is
well known for promoting mouse embryonic stem (ES) cell self-
renewal (Williams et al., 1988) and the long-term growth of em-
bryonic human NSCs in culture (Wright et al., 2003). Other
reports indicate that LIF signaling supports the maintenance/
self-renewal of cultured mouse embryonic NSCs (Shimazaki et
al., 2001; Pitman et al., 2004; Bonaguidi et al., 2005; Gregg and
Weiss, 2005), possibly by activating Notch signaling (Chojnacki
et al., 2003). However, little is known about the influence of LIF
signaling onNSCs and neurogenesis in vivo: gp130 regulates cell-
cycle reentry of embryonic cortical progenitors (Hatta et al.,
2002), and exogenous CNTF enhances neurogenesis in the adult
brain (Emsley and Hagg, 2003; Kokoeva et al., 2005).
To clarify the effects of LIF on NSCs and neurogenesis in vivo,
we overexpressed LIF in the uninjured, adult mouse forebrain. In
contrast to CNTF (Emsley andHagg, 2003; Kokoeva et al., 2005),
we find that exogenous LIF reduces neurogenesis in the subven-
tricular zone (SVZ)/olfactory bulb (OB) system. This is attribut-
able, in part, to a direct effect of LIF on adult NSCs: LIFmaintains
them in a loop of symmetric/self-renewing divisions in vivo,
which prevents the emergence of more differentiated progeny.
LIF ultimately increases the pool of NSCs, which could be ex-
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ploited to accelerate the regeneration of the SVZ. Our data sug-
gest that LIF may be useful for cell replacement in situ.
Materials andMethods
Animals.We used adult male C57BL/6J mice of various ages. In the first
experiment, 16-month-old animals were obtained from the National
Institute on Aging and our own breeding colonies and were injected with
recombinant adenoviruses (see below). All other experiments were per-
formed on 2- to 6-month-old animals obtained from The Jackson Lab-
oratory (Bar Harbor, ME). All experiments were approved by the Cali-
fornia Institute of Technology Institutional Animal Care and Use
Committee.
Bromodeoxyuridine. Bromodeoxyuridine (BrdU; Sigma, St. Louis,
MO) was dissolved in 0.9% NaCl, sterile filtered, and injected intraperi-
toneally (100 mg/kg) according to the protocols indicated below.
Adenovirus injection.Recombinant adenoviruses (2.7 106 pfu in 3
l of sterile PBS) encoding LacZ (Ad:LacZ) or LIF (Ad:LIF) (Zhu et al.,
2001) were injected into the right lateral ventricle (0.1 mm anteropos-
terior relative to bregma, 0.9 mm lateral from the midline, and 2.5 mm
below the dura) using a 5 l Hamilton syringe attached to a 28-gauge
needle. Injections were performed over 3–5 min, and the needle was left
in place for another 6–10 min before withdrawal.
In the first experiment, mice were injected with Ad:LIF or Ad:LacZ
(n 5 per group) and received single BrdU injections for 7 d, starting 2
weeks after adenovirus injection. Thesemice were killed 2 weeks after the
first BrdU injection (1week after the last BrdU injection and 4weeks after
adenovirus injection).
Other mice were killed 3 weeks after adenovirus injection and were
used to obtain SVZ-derived neurospheres or to assess long-term, label-
retaining cells in the SVZ (see below).
Retrovirus production and injections. A replication-incompetent green
fluorescent protein (GFP) retrovirus, pseudotyped with vesicular stoma-
titis virus glycoproteinG (VSV-G), was produced according to published
methods.Human embryonic kidney 293 (HEK293) cells were transiently
transfected with plasmids containing gag-pol and vsv-g under the control
of the cytomegalovirus (CMV) promoter and the virus plasmid (pNIT)
containing long-terminal repeat-driven GFP (a gift from F. H. Gage, The
Salk Institute, San Diego, CA), using Polyfect (Qiagen, Valencia, CA).
Medium containing viral particles was collected 40 and 64 h after trans-
fection and centrifuged each day at 50,000 g for 2 h at 4°C (Beckman
centrifuge model L8-M, rotor SW-28; Beckman Coulter, Fullerton, CA).
Pellets obtained after each centrifugation were resuspended in sterile
PBS, mixed together, and centrifuged again. The final pellet was resus-
pended in 200 l of sterile PBS (concentrated by a factor of 1800), ali-
quoted, and stored at80°C. Titer was determined to be1 107 cfu
(colony-forming units)/ml using HEK293 cells.
The GFP retrovirus was injected bilaterally into the SVZ of 2-month-
old mice. Three injections of 400 nl each were performed per SVZ using
a 1 l Hamilton syringe attached to a beveled glass micropipette (14
m inner diameter) at the following coordinates [anterior relative to
bregma, lateral, depth below the dura (in mm)]: 0, 2, 2; 0.5, 1.2, 2.2; and
1,1, 2. Immediately after the injection of the GFP retrovirus, animals
received an injection of Ad:LIF or Ad:LacZ (n 2 in each group) into the
right lateral ventricle.
SVZ regeneration. Cytosine--D-arabinofuranoside (AraC; 2%;
Sigma) in saline was infused for 6 d into the lateral ventricle (same coor-
dinates as for adenovirus injection) using osmotic mini-pumps (model
1007D, Alzet; Durect, Cupertino, CA) implanted subcutaneously on the
back of the animals and connected to a brain infusion kit 2 or 3 cannula
(Alzet).
Recombinant mouse LIF protein (Millipore, Billerica, MA), human
epidermal growth factor (EGF; Invitrogen, Carlsbad, CA), or PBS [with
or without bovine serum albumin (BSA)] were infused before or after
AraC using mini-pump model 1003D (for 1 and 3 d; 1 l/h) or 1007D
(for 7 d; 0.5l/h; Alzet).Mini-pumpswere filledwith LIF protein diluted
in PBS (5 g/ml), resulting in the delivery of 60 or 120 ng of LIF per day
(for pump models 1007D and 1003D, respectively). EGF (16.67 g/ml)
was dissolved in PBS containing 0.1% BSA and infused at 400 ng/d,
similar to other studies (Shimazaki et al., 2001; Doetsch et al., 2002).
Mice (n 3 per group and per experiment) were killed at 1, 3, or 7 d
after AraC removal, 1–2 h after a single BrdU injection.
Double nucleoside administration. Mice (2 months of age) were given
iododeoxyuridine (IdU) or chlorodeoxyuridine (CldU) (both from
Sigma) in their drinking water (1 mg/ml), supplemented with 2.5% su-
crose. The solution was made fresh and changed daily.
IdUwas administered first for 2weeks, followed by 1weekwith regular
water containing no marker. Animals were then injected with Ad:LIF or
Ad:LacZ in the lateral ventricle (n  3 per group) and treated on the
following day with CldU for another 2 weeks. Animals were perfused
after 1more weekwith regular water containing nomarker (i.e., a total of
4 weeks after the end of IdU treatment). All animals drank similar
amounts of water throughout the treatment period (an average of 5.5
ml/d).
Tissue processing and histology. Animals were perfused transcardially
with 0.1 M phosphate buffer (PB), pH 7.5, followed by fresh, cold 4%
paraformaldehyde in PB. Brainswere dissected and fixed another 3–5 h at
4°C, washed overnight in PB at 4°C, and immersed overnight at 4°C in PB
containing 20% sucrose. Brains were then embedded in freezing media
(optimum cutting temperature), frozen in chilled isopentane (25°C),
and stored at80°C until sectioning.
Coronal brain sections (14 m) were collected on Superfrost Plus
slides (Fisher Scientific, Pittsburgh, PA) using a cryostat (model
CM3050; Leica Microsystems, Bannockburn, IL) and dried overnight at
room temperature before being stored at20°C.
Immunohistochemical staining was performed according to standard
procedures. Staining for BrdU and double staining for IdU and CldU
were as described previously (Bauer and Patterson, 2005). The primary
antibodies used were mouse anti-NeuN (Millipore), mouse anti-Ki67
and anti-mammalian achaete-scute homolog 1 (Mash1) (both from BD
Biosciences PharMingen, San Jose, CA), rabbit anti-LIFR and goat anti-
doublecortin (Dcx) (both from Santa Cruz Biotechnology, Santa Cruz,
CA), sheep anti-EGF receptor (EGFR; Millipore), rabbit anti-GFP (In-
vitrogen), rabbit anti-S100 (Dako, Carpinteria, CA), rabbit anti-
phosphorylated Stat3 (Y705; Cell Signaling Technology, Beverly, MA),
goat anti-Olig2 (R & D Systems, Minneapolis, MN), and rat or mouse
anti-BrdU (Oxford Biotechnology, Oxfordshire, UK and BDBiosciences
PharMingen, respectively). Species-specific secondary antibodies conju-
gated to Alexa 488, 568, or 633 were from Invitrogen.
Quantification and image analysis. Staining was analyzed with a Nikon
(Tokyo, Japan) microscope (model Diaphot 300) and an LSM510 con-
focalmicroscope (Zeiss, Thornwood,NY) equippedwith an argon/kryp-
ton laser (488 nm), two helium/neon lasers (543 and 633 nm), and a
Coherent (Santa Clara, CA) Chameleon two-photon laser [used at 725
nm to image DAPI (4,6-diamidino-2-phenylindole dihydrochloride)
staining]. Pictures were obtained with a Spot RT Slider camera and asso-
ciated software (version 3.4; Diagnostic Instruments, Sterling Heights,
MI) or with the LSM software (Zeiss). Colocalizations were investigated
by performing z-stack acquisitions and three-dimensional reconstruc-
tions. Adobe Photoshop version 7.0.1 (Adobe Systems, San Jose, CA)was
used to adjust contrast and brightness.
Sections sampled at similar anatomical levels of the OB or the SVZ
(between0.3 and0.7mmanterior relative to bregma)were processed
at the same time for each type of staining. Quantification was performed
at the confocal microscope or with the Nikonmicroscope using a 40 or
an oil-immersion 63 objective. Single and double-labeled cells were
hand scored in various structures of interest by an observer blind to the
treatment of the animals. Cells were quantified on two to six equally
spaced (42 m) sections per animal. Cell numbers are expressed as
mean SEM per section for each structure (no difference in the size of
the OB or SVZwas observed between animals from different experimen-
tal groups).
For image analysis of the Dcx and GFP staining, black-and-white pic-
tures of three to four equally spaced (42 m) sections per animal were
taken with the Nikon microscope using constant settings across various
animals from the same experiment. Image analysis was performed using
the NIH ImageJ software (version 1.34s) by quantifying the staining area
after adjusting the threshold manually. Results are expressed as mean
SEM pixel 2 per section.
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Neurosphere cultures and quantification. Neurospheres were obtained
from micro-dissected adult mouse SVZ (Doetsch et al., 1999a). SVZ
fragments were digested in papain (Sigma) and trypsin (Invitrogen) so-
lution for 20 min at 37°C and mechanically dissociated by passing
through a 26-gauge needle (Charrier et al., 2006). Single cells were seeded
at 10 cells per microliter in 24-well plates (500 microliters per well) in
serum-free media consisting of DMEM supplemented with B27, penicil-
lin/streptomycin, 20 ng/ml EGFwith orwithout 10 ng/ml basic fibroblast
growth factor (FGF) (all from Invitrogen), and sodium pyruvate
(Sigma).
After 6–9 d in cultures, spheres were collected, incubated in TripLE
Express (Invitrogen) for 30–60 min at 37°C, mechanically dissociated,
and reseeded as single cells as described above. Experiments involving
single cells or neurospheres exposed to LIF (20 ng/ml) were performed
after four or more passages.
In each experiment, neurospheres were quantified in three to six wells
and further classified according to their size (100 m diameter). Re-
sults are presented as mean SEM neurospheres per well (i.e., per 5000
cells). Each experiment was repeated at least three times.
Statistics. Statistics were performed using the unpaired Student’s t test.
Results are considered significant when the p value is	0.05.
Online supplemental material. Supplemental Figure S1 illustrates the
bioactivity of virally overexpressed LIF, assessed by phosphorylated Stat3
(pStat3) staining. Supplemental Figure S2 shows expression of LIFR on
various SVZ cell types. Supplemental Figure S3 offers a comparison be-
tween the in vitro and in vivo effects of LIF. The supplemental material is
available at www.jneurosci.org.
Results
LIF reduces neurogenesis in the OB
We focused our study on the SVZ, a well described system that
generates neurons in the OB (for review, see Doetsch, 2003). The
SVZ contains NSCs, the type B cells that express the astrocyte
marker glial fibrillary acidic protein (GFAP) (Doetsch et al.,
1999a; Garcia et al., 2004), the immediate progeny of which are
the transit-amplifying, type C cells. Type C cells divide rapidly
and generate neuroblasts, the type A cells, which migrate toward
the OB (Doetsch et al., 1997).
To investigate the effects of overexpressing LIF on adult NSCs
and neurogenesis, adult mice were injected in the lateral ventricle
with an adenovirus encoding a secreted form of LIF (Ad:LIF) or
-galactosidase (Ad:LacZ) as a control (Zhu et al., 2001). Two
weeks after virus inoculation, mice received daily intraperitoneal
injections of BrdU for 7 d and were killed 1 week later (2 weeks
after the first BrdU injection).
Adenoviruses efficiently infect ependymal cells when injected
into the lateral ventricle (Doetsch et al., 1999a). Accordingly, we
found that LIF or X-Gal (5-bromo-4-chloro-3-indolyl--D-
galactopyranoside) staining is confined to ependymal cells (data
not shown). To confirm LIF activity in vivo, we performed pStat3
staining. Staining is abundant and localized to cell nuclei in Ad:
LIF-treated animals, but not in Ad:LacZ-injected controls (sup-
plemental Fig. S1, available at www.jneurosci.org as supplemen-
tal material). pStat3 staining intensity appears stronger in areas
immediately adjacent to the ventricle, whereas it decreases farther
away from the ventricle in a gradient-like pattern, suggesting
maximal LIF activity in and around the SVZ.
In theOB, BrdU cells, either single labeled or colabeled with
the mature neuronal marker NeuN, are mostly found in the sub-
ependymal and granule cell layers (Fig. 1), where newborn neu-
rons are expected 1–2 weeks after being generated. Overexpres-
sion of LIF significantly reduces the number of both classes of
cells in these anatomical layers, without affecting the percentage
of newly generated neurons (Fig. 1). This suggests that LIF does
not alter early neuronal differentiation or radial migration in the
OB proper, but rather reduces the number of newly generated
cells coming from the SVZ that reach the OB. Thus, LIF may act
“upstream” of the OB by altering SVZ cell fate.
LIF impairs neuroblast formation in the SVZ
We first checked whether cell proliferation in the SVZ is altered
by LIF overexpression. In Ad:LIF-treated mice, the number of
cells labeled with BrdU or with the endogenous cell-cycle marker
Ki67 is only one-half of that in controls (Fig. 2), indicating that
exogenous LIF strongly reduces SVZ cell proliferation. In con-
trast to the SVZ, other areas analyzed at the same anatomical level
[i.e., the corpus callosum, striatum, and septum (hereafter re-
ferred to as periventricular areas)], as well as the cortex, all con-
tain more Ki67 or BrdU cells after LIF overexpression (Fig. 2).
In the SVZ, most of the proliferating cells correspond to neu-
roblasts (typeA) and transit-amplifying cells (typeC) (Doetsch et
al., 1997). InAd:LIF-treated animals,Dcx-expressing neuroblasts
Figure 1. LIF reduces neurogenesis in the OB. A, Double staining for BrdU and the mature
neuronal marker NeuN indicates that most BrdU cells are found in the two deepest anatom-
ical layers of the OB: the subependymal layer (SEL) and the granule cell layer (GCL). B, An
exampleof colocalizationbetweenBrdUandNeuN.C, ThenumberofBrdU cells, aswell as the
number of newly generated neurons (BrdU/NeuN), is reduced by 41–51% in animals
overexpressingLIF (Ad:LIF) comparedwith controls (Ad:LacZ),whereas thepercentageofnewly
generated neurons is unchanged (6.3 0.8 vs 7.2 0.9% and 25.0 1.4 vs 23.5 1.4% in
Ad:LacZ- vs Ad:LIF-treated animals in the SEL andGCL, respectively; p 0.2). Data aremean
SEM of n 5 animals per group (2–3 sections analyzed per animal). **p	 0.01 and ***p	
0.001 compared with Ad:LacZ-treated controls (Student’s t test). Scale bars: A, 300m; B, 10
m. RMS, Rostral migratory stream; Gran, granule cell layer.
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(Brown et al., 2003) are virtually absent
(Fig. 3) (image analysis of Dcx staining in
the SVZ: 6334.80  309.89 vs 935.73 
90.65 pixel 2 in Ad:LacZ- vs Ad:LIF-treated
animals; p 	 0.001), and Mash1-
expressing type C cells (Fig. 3) (Parras et
al., 2004) are greatly reduced (down

70%; 57.80  4.39 vs 16.80  1.61
Mash1 cells in Ad:LacZ- vs Ad:LIF-
treated animals; p 	 0.001), indicating
that LIF overexpression depletes the SVZ
of cells in the neuronal lineage.
To better understand how LIF may be
acting in the SVZ,we stained sections from
naive animals with LIFR antibodies. Im-
munoreactivity is detected in all SVZ cell
types (supplemental Fig. S2, available at
www.jneurosci.org as supplemental mate-
rial), including some GFAP astrocytes
(type B cells) (Fig. 3). Thus, the previous
data could be explained by several differ-
ent mechanisms: LIF could directly (1) re-
duce the proliferation or (2) alter the fate
of type A and C cells. It is also possible that
the depletion of neuronal cells in the SVZ
could be the consequence of (3) a direct
effect of LIF on NSCs (type B), which
would prevent the normal generation of
NSC progeny, the type C and type A cells.
LIF stimulates the proliferation of
parenchymal glial progenitors in
periventricular areas
LIF may promote glial cell fate at the ex-
pense of the neuronal lineage in vivo, as it
does in vitro (Bonni et al., 1997; Chang et
al., 2004; Barnabe-Heider et al., 2005; He
et al., 2005), which could explain the de-
pletion of neuronal cells in the SVZ. Con-
sistent with this hypothesis, phenotypic
analysis in periventricular areas and the
cortex of Ad:LIF-treated animals reveals a
threefold to fivefold increase in BrdU
cells expressingOlig2 or S100, two glial cell
markers (Fig. 4). No newly generated
Dcx neurons are found, indicating that
LIF does not stimulate neurogenesis in
these areas (data not shown).
Interestingly, BrdU cells appear to be
distributed in a gradient-like pattern sim-
ilar to the pStat3 staining, suggesting that
LIF could induce SVZ cells to migrate out
of the SVZ and invade periventricular ar-
eas, where they would adopt a glial pheno-
type. To check whether BrdU cells are
derived from the SVZor from local, paren-
chymal progenitors, we labeled SVZ cells
and their progeny by injecting a GFP-
replication-incompetent retrovirus in the
SVZ before treatment with Ad:LIF or Ad:
LacZ. Three weeks after virus injections,
GFP cells with themorphology and phe-
notype of immature neurons were seen in
Figure 2. LIF reduces cell proliferation in the SVZ. A, Double staining for BrdU and the endogenous cell-cycle marker Ki67 is
shownon representative sections froma control animal (Ad:LacZ) and an animal overexpressing LIF (Ad:LIF). CC, Corpus callosum;
St, striatum; LV, lateral ventricle. Note the highly organized aspect of the SVZ in the control animal comparedwith treatmentwith
Ad:LIF, in which fewer labeled cells are seen in the SVZ, but more in periventricular areas. B, Higher magnification of SVZ cells
double stainedwithBrdUandKi67.C,D, Quantification of BrdU (C) andKi67 (D) cells is shown for various brain regions at the
anatomical level analyzed (between0.3 and0.7 mm anterior to bregma). There is a 53–55% reduction in both classes of
labeled cells in the SVZ of Ad:LIF-treated animals. In contrast, LIF overexpression triggers an increase in BrdU as well as Ki67
cells in periventricular areas [CC, St, and septum (Sept)] and the cortex (Cx). Data are mean SEM of n 5 animals per group
(2–3 sections analyzedper animal). *p	0.05 and***p	0.001 comparedwithAd:LacZ-treated controls (Student’s t test). Sept
SVZ, The ependyma lining the septal side of the lateral ventricle. Scale bars: A, 150m; B, 15m.
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the OB of all animals (Fig. 4). However, no GFP cells were
found in the striatum or septum of either group ofmice (data not
shown), suggesting that cells derived from the SVZ do not mi-
grate normally in these areas and that LIF does not promote such
ectopic migration. The corpus callosum in both Ad:LIF and Ad:
LacZmice contains some GFP cells, likely because of the lesion
induced at the time of virus injections. These results indicate that
LIF-induced proliferation in periventricular areas, mostly glial in
nature, originates from parenchymal, “activated” glial progeni-
tors and not from SVZ-derived cells, which suggests a reactive
gliosis that could be attributable to the proinflammatory effects
of LIF (Sugiura et al., 2000; Kerr and Patterson, 2004). Thus, the
reduction in SVZprogenitors andOBneu-
rogenesis cannot be explained by an emi-
gration or a change in cell fate of cells from
the SVZ.
We also found that the number of
GFP cells is reduced by
60% in the OB
of Ad:LIF-treated animals (Fig. 4) (image
analysis of GFP staining in the OB:
1703.75 127.76 vs 576.60 45.18 pixel 2
in Ad:LacZ- vs Ad:LIF-treated animals;
p 	 0.001), consistent with and confirm-
ing our previous observations with BrdU
and NeuN. Given that the GFP retrovirus
is likely infecting a majority of type C and
A cells when injected into the SVZ, this
result suggests that LIF is acting directly on
these types of progenitors.
LIF impairs the amplification of type C
cells and stimulates the formation of
SVZ astrocytes
The above data indicate that the depletion
of neuronal cells observed in the SVZ after
LIF overexpression results from a deregu-
lation of cell lineage homeostasis that is
spatially restricted to the SVZ. It is possible
that LIF impairs the amplification of type
C cells and the transition to type A cells.
We studied self-renewal/cell cycle kinetics
in the SVZby analyzingKi67/BrdUdouble
staining using animals that were killed 1
week after the last BrdU injection. This 1
week survival allows most migrating
BrdU neuroblasts to be cleared from the
SVZ and reach the OB. Hence, BrdU
cells that are left in the SVZ and that coex-
press Ki67 correspond to self-renewing
cells or to cells with a long cell cycle (1
week; i.e., type C or type B cells). Given
that the NSC fraction (B cells) is estimated
to represent only 0.2–0.4% of the SVZ,
and that C cells reside for
2 weeks in the
SVZ (Morshead et al., 1998), the majority
of the Ki67/BrdU cells in our experi-
ment likely correspond to self-renewing
type C cells. LIF reduces the number of
Ki67/BrdU cells by
50% (33.3 2.0
vs 17.5  2.2 Ki67/BrdU cells in Ad:
LacZ- vs Ad:LIF-treated animals; p 	
0.001), consistent with the reduction of C
cells observed with Mash1. Because LIF
also reduces proliferation, an index of self-renewal was calculated
by dividing the number of self-renewing cells (BrdU/Ki67)
by the total number of BrdU cells. This ratio is significantly
decreased in the dorsolateral corner of the SVZ (14.6  2.1 vs
8.9  1.7% in Ad:LacZ- vs Ad:LIF-treated animals; p  0.02),
suggesting that LIF overexpression reduces type C cell
self-renewal.
It is also possible that LIF could act directly on NSCs, as sug-
gested by the localization of LIFR on SVZ GFAP cells (Fig. 3),
and impair type C cell production. Interestingly, we found that
the SVZ of Ad:LIF-treated animals contains fivefold more
Olig2 or S100 cells colabeled with BrdU compared with con-
Figure 3. LIF reduces neuronal differentiation in the SVZ, and LIFR is expressed by some SVZ astrocytes. A, Dcx-expressing
neuroblasts (type A cells) are greatly reduced in the SVZ of animals treated with Ad:LIF (see Results for image analysis data). B,
High magnification of SVZ cells stained with Mash1, a marker of transit-amplifying, type C cells. Note the mitosis (arrows and
insets). C, LIFR immunoreactivity is detected on some GFAP-expressing astrocytes in the SVZ. Scale bars: A, 200m; B, 30m
(insets, 15m); C, 15m.
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trols (Fig. 4), indicating that the depletion
of neuronal cells is counterbalanced by an
increased formation of glial cells. Interest-
ingly, Olig2 expression has recently been
identified in a subset of type B cells and
colocalizes with S100 in some SVZ cells
(Menn et al., 2006). Most noteworthy,
many S100/BrdU cells in the SVZ of
Ad:LIF-treated animals also express GFAP
(Fig. 4), a marker of neural stem type B
cells (Doetsch et al., 1999a; Garcia et al.,
2004). Thus, LIF appears to promote the
proliferation or formation of SVZ astro-
cytes, at the expense of other SVZ cell
types. These SVZ astrocytes may corre-
spond to differentiated astrocytes that lose
their stem cell potential, which would be
consistent with the well known astrocyte-
promoting effect of LIF in vitro, or to pu-
tative NSCs. Either effect would decrease
the formation of type C and type A cells
and reduce subsequent OB neurogenesis.
Infusion of LIF after AraC impairs SVZ
regeneration in vivo
To address the possibility that LIF directly
affects NSCs in vivo, we examined how the
SVZ regenerates in the presence of LIF, af-
ter infusion of the antimitotic drug AraC
(Doetsch et al., 1999b). AraC kills actively
proliferating SVZ cells, type A and C cells,
but spares type B cells (NSCs), which pro-
liferate after AraC removal and sequen-
tially regenerate type C and type A cells
(Doetsch et al., 1999b). AraC was infused
in the lateral ventricle for 6 d and was fol-
lowed by infusion of recombinant LIF pro-
tein or PBS as a control. Mice were killed
1–2 h after a single BrdU injection 1, 3, or
7 d after AraC removal/LIF infusion, when
type B, type C, and type A cells reappear
and massively proliferate, respectively
(Doetsch et al., 1999b).
At all time points examined after AraC
removal, SVZ cell proliferation (BrdU
staining) is reduced by 
50% in animals
infused with LIF compared with controls
(Fig. 5). As expected, the number of
BrdU cells increases in controls between
1 and 3 d of regeneration, reflecting the
reappearance of type C cells from NSCs
(Doetsch et al., 1999b). However, no such
increase is apparent in LIF-treated animals
(Fig. 5), suggesting that type C cells do not
fully reappear. Indeed, proliferating C
cells, identified by coexpression of BrdU
and the EGFR (Doetsch et al., 2002) (Fig.
5), are strongly reduced (70%) in LIF-
treated animals (71.67  4.65 vs 21.33 
3.52 BrdU/EGFR cells in PBS-infused
controls vs LIF-treated animals; p 	
0.001). Furthermore, BrdU/EGFR
cells account for only 50% of the prolifer-
Figure 4. LIF promotes the proliferation or formation of glial progenitors in periventricular areas and in the SVZ. A, B, Quan-
tification of cells coexpressing BrdU and S100 (A) or BrdU and Olig2 (B) indicates that LIF overexpression induces a threefold to
fivefold increase in the number of these newly generated glial cells in all brain regions examined, including the SVZ. C, D, A
GFP-replication-incompetent retrovirus was injected into the SVZ before treatment with Ad:LacZ (control) or Ad:LIF, and brains
were examined3weeks after injection.C, A GFPneuron in theOBdisplays dendritic spines but lacks expression of the immature
neuronmarker Dcx.D, Representative OB sections show that GFP cells are concentrated in the center of the OB and are reduced
in animals treated with Ad:LIF (see Results for image analysis data). E, In the SVZ of Ad:LIF-treated animals, many cells that are
double stained with BrdU and S100 also express GFAP, a marker of NSCs. Data are mean SEM of (Figure legend continues.)
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ating cells in animals infused with LIF, whereas their proportion
reaches 70% in controls ( p  0.005), as reported previously
(Doetsch et al., 1999b). Thus, these results indicate a lack of or
delay in the generation of type C cells from NSCs when the SVZ
regenerates in the presence of LIF. Some neuroblasts do reappear
7 d after AraC removal/LIF infusion, but to a much lower extent
than in control (Fig. 5) (image analysis of Dcx staining in the
SVZ: 4383.22 595.84 vs 1116.22 92.10 pixel 2 in PBS vs LIF-
infused animals; p	 0.001).
Altogether, our results indicate that LIF acts directly on NSCs
in vivo and prevents the normal generation of NSCs progeny
during the regeneration process.
LIF promotes adult NSC self-renewal in vivo and in vitro
LIF could prevent the emergence of more differentiated progeny
as a result of promoting symmetric cell division and self-renewal
of adult NSCs in vivo. To analyze the effects of LIF on NSC self-
renewal, we first used the neurosphere assay in vitro. Adult SVZ-
derived neurospheres were grown in proliferative conditions for
6 d in vitro (DIV) and exposed to LIF for the last 2 DIV, which
does not change the number or size of the neurospheres (supple-
mental Fig. 3, available at www.jneurosci.org as supplemental
material). Neurospheres were then dissociated, and single cells
were replated in normal proliferative conditions without LIF for
another 7–9 DIV to score the number of secondary neurospheres
generated. The transient incubation in LIF during the last 2 DIV
increases secondary sphere formation by nearly 70% (Fig. 6).
These neurospheres could be passaged and were multipotent
(data not shown), suggesting that LIF promotes the self-renewal
of sphere-forming cells with NSC characteristics in vitro.
To determine whether LIF also stimulates the self-renewal of
NSCs in vivo, we made use of the fact that stem cells retain exog-
enous thymidine analogs after long-term survival (Morshead et
al., 1994, 1998; Doetsch et al., 1999a). We further refined this
method by using a double nucleoside labeling strategy tomonitor
the proportion of long-term, label-retaining cells that reenter the
cell cycle (Maslov et al., 2004). In this experiment, adult mice
were given nucleoside analogs in their drinking water, starting
with a 2 week treatment with IdU, followed by 1 week without
label and by an Ad:LIF or Ad:LacZ injection. Mice were then
given CldU for another 2 weeks, followed by 1 week without label
before they were killed, a total of 4 weeks after the end of IdU
administration. In this experiment, the SVZ should contain long-
term, label-retaining cells that are IdU, some of which become
quiescent, whereas others are still proliferating and likely corre-
spond to self-renewing NSCs, which can thus be identified by the
incorporation of both markers, IdU and CldU.
Ad:LIF treatment increases the number of IdU cells (by

30%) (Fig. 6), indicating that LIF promotes the retention of
long-term, label-retaining cells in the SVZ. Importantly, LIF also
produces a twofold increase in the number of cells double labeled
with IdU andCldU and increases the proportion of self-renewing
cells (IdU/CldU) among the total number of long-term,
label-retaining cells (IdU) (Fig. 6). These data indicate that LIF
promotes the formation of long-term, label-retaining cells that
reenter the cell cycle, which are candidate NSCs. Although it is
possible that some IdU/CldU cells correspond to type C cells,
their contribution in our experiment is likely minimal, because
we find that LIF strongly reduces the number of C cells. Further-
more, previous studies found that the only SVZ cells labeled 1
month after nucleoside administration are the type B cells
(Doetsch et al., 1999a). Thus, the increase in IdU/CldU cells
likely reflects a greater number of NSCs that reenter the cell cycle,
4
(Figure legend continued.)n5animals pergroup (2–3 sections analyzedper animal). ***p	
0.001 comparedwithAd:LacZ-treated controls (Student’s t test). Sept SVZ, Ependyma lining the
septal side of the lateral ventricle; Cx, cortex; CC, corpus callosum; LV, lateral ventricle; St,
striatum; Sept, septum. Scale bars: C, 50m; D, 300m; E, 10m.
Figure5. Infusionof LIF after a 6dAraC treatment impairs SVZ regeneration in vivobyacting
directly on NSCs. A, Quantification of BrdU cells in the SVZ indicates that LIF reduces the
number of BrdU cells at 1, 3, and 7 d after AraC removal. B, High magnification of SVZ cells
double stained for BrdU and EGFR, a marker of transit-amplifying cells (type C). C, Representa-
tive sections stained with Dcx (amarker of neuroblasts) 7 d after AraC removal/LIF infusion. LIF
strongly impairs the reappearance of neuroblasts (see Results for image analysis data). Data are
mean SEM of n 3 animals per group (2–3 sections analyzed per animal). **p	 0.01 and
***p	 0.001 compared with PBS-infused controls (Student’s t test). Scale bars: B, 15 m
(inset, 30m); C, 200m.
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suggesting that LIF promotes the self-
renewal of proliferating NSCs in vivo.
In conclusion, our results strongly sug-
gest that LIF expands the pool of adult
NSCs by promoting their self-renewal,
thereby preventing the emergence of more
differentiated progeny, both in vivo and in
vitro.
Infusion of LIF before AraC promotes
SVZ regeneration
Therapeutic strategies for brain repair in-
clude the stimulation of endogenous pro-
genitors to promote cell replacement.
Thus, it is of interest to determine whether
the increased number of NSCs induced by
LIF treatment in vivo may be useful in re-
generation of cell populations. Given the
strong correlation between the effects of
LIF on sphere formation in vitro and on
the early phases of SVZ regeneration in vivo
(supplemental Fig. 3, available at www.
jneurosci.org as supplemental material),
and because LIF exposure for the last 2
DIV strongly stimulates secondary sphere
formation, we asked whether a previous,
short-term exposure to LIF in vivo in a
normal SVZ environment, before infusing
AraC, leads to a stimulation of the regen-
erative process (the equivalent of an in-
creased secondary sphere formation).
We tested this by infusing LIF or PBS
for 3 d in the lateral ventricle before a 6 d
AraC infusion. Animals received a single
BrdU injection 1 h before they were killed,
3 d after AraC removal. Remarkably, the
number of BrdU or Ki67 cells is signif-
icantly increased in the SVZ of animals
treated with LIF before AraC, as is the
number of proliferating EGFR type C
cells (Table 1). In contrast, a 3 d infusion of
EGF instead of LIF before AraC infusion
has no effect on subsequent SVZ regener-
ation (Table 1), indicating that the effects
of LIF are specific. Because EGF acts pri-
marily on type C but not type B (NSCs)
cells (Doetsch et al., 2002), this suggests
that LIF-mediated acceleration of SVZ re-
generation results from an effect on NSCs.
Furthermore, we find that SVZ cell prolif-
eration, although strongly decreased by a
3 d LIF infusion, quickly returns to near-
control levels as soon as 1 d after LIF re-
moval (data not shown), making it un-
likely that type C cells could be protected
from AraC-induced degeneration.
Thus, our data indicate that LIF infusion, before inducing
SVZ degeneration, accelerates the subsequent regenerative pro-
cess, possibly as a result of expanding the pool of NSCs through
the promotion of self-renewing divisions. This could be attribut-
able to a direct effect of LIF on NSCs or, alternatively, could
be mediated indirectly, through cells activated by LIF outside
the SVZ.
Discussion
The adult SVZ, where newOBneurons are born, contains rapidly
dividing progenitors, neuroblasts and transit-amplifying cells,
the type A and type C cells, respectively. We find that exogenous
LIF strongly reduces SVZ cell proliferation and subsequent neu-
rogenesis in the adult OB. At the same time, we find that LIF
promotes the self-renewal of NSCs, ultimately expanding this
Figure 6. LIF stimulates the self-renewal of sphere-forming cells in vitro, as well as the renewal of long-term, label-retaining
cells in vivo. A, Schematic representation of the protocol used in vitro. Growing neurospheres were incubated with LIF (20 ng/ml)
during the last 2 DIV. These neurospheres were then dissociated to assess secondary neurosphere formation. B, Quantification of
secondary spheres. Neurospheres pretreated with LIF during the last 2 DIV (from 6 to 8 DIV) yield 70% more secondary neuro-
spheres comparedwith neurospheres thatwere not exposed to LIF. This increase is observed on the total population of spheres as
well as on larger neurospheres (100mdiameter). C, Pictures illustrate an example of the IdU and CldU double staining.D, LIF
induces a 30% increase in the number of long-term, label-retaining cells (IdU), as well as a twofold increase in the number of
long-term, label-retaining cells that reenter the cell cycle (IdU/CldU). LIF also increases the proportion of IdU/CldU cells
among the total IdU cells (Index; i.e., the proportion of self-renewing, long-term, label-retaining cells that reenter the cell
cycle). Data are mean SEM of n 3 animals per group (3 sections analyzed per animal) or n 3–6 wells per condition
(independent experiments were performed at least 3 times and gave similar results). **p	 0.01 and ***p	 0.001 compared
with Ad:LacZ-treated control animals or spheres incubated without LIF (Student’s t test). Scale bar: C, 30m (inset, 60m).
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discrete cell population, which normally represents only
0.2–0.4%of the SVZ cells. Thus, chronic overexpression of LIF in
vivo maintains NSCs in a loop of symmetric/self-renewing divi-
sions, preventing the emergence of more differentiated progeny.
A similar deregulation of the SVZ cell lineage in vivo has been
described after application of exogenous EGF, which also reduces
neurogenesis but does so by acting on transit-amplifying cells
(Doetsch et al., 2002).
Our results are consistent with and expand on recent studies
examining the in vitro effects of LIF on embryonic neurospheres
(Pitman et al., 2004; Bonaguidi et al., 2005), in which LIF pro-
motes secondary sphere formation. Although LIF induces a
marker of astrocyte differentiation (GFAP), the morphology and
phenotype of these LIF-treated cells is distinct from astrocytes
generated in the presence of bonemorphogenic proteins (BMPs),
another gliogenic cytokine family (Bonaguidi et al., 2005). Major
differences include bipolar/elongated/radial morphology in LIF
but a stellate morphology in BMPs and expression of radial glial
markers such as vimentin in LIF but not in BMPs (Bonaguidi et
al., 2005). Furthermore, proliferation continues in the presence
of LIF but is strongly inhibited in BMPs, and neurospheres can be
obtained very efficiently from LIF-generated astrocytes, but not
from astrocytes generated in BMPs (Bonaguidi et al., 2005). In-
terestingly, the bipolar/elongated/radial morphology of LIF-
generated astrocytes is reminiscent of the morphology described
in vivo for adult GFAP-expressing NSCs (Garcia et al., 2004) and
is consistent with our findings (Fig. 4). Overexpressing BMP in
vivo prevents cell proliferation and neurogenesis in the adult SVZ
(Lim et al., 2000), similar to our findings with LIF. In the hip-
pocampus, overexpression of BMPs reduces proliferation and
downregulates the expression of neural progenitor markers in
GFAP cells (Bonaguidi et al., 2005). Thus, BMPs induce differ-
entiation of GFAP-expressingNSCs into astrocytes that lose their
stem cell potential, whereas LIF maintains their stem cell charac-
teristics. Despite our findings that LIF acts on NSCs during SVZ
regeneration and that LIFR is expressed on some GFAP cells,
we cannot exclude the possibility that LIF promotes GFAP ex-
pression in a subset of type C cells, whichmay dedifferentiate and
acquire NSC characteristics, similar to the effects of exogenous
EGF treatment (Doetsch et al., 2002). Indeed, EGFR signaling
synergizes with LIF to induce astrocyte differentiation (Viti et al.,
2003), and we also find colocalization of EGFR with LIFR (sup-
plemental Fig. 2, available at www.jneurosci.org as supplemental
material).
In contrast to the effects of LIF described in our study, exog-
enous CNTF stimulates SVZ cell proliferation (Shimazaki et al.,
2001) and neurogenesis in the adult brain (Emsley and Hagg,
2003; Kokoeva et al., 2005), suggesting that LIF and CNTF have
different biological effects. Indeed, slightly more neurospheres
were derived from the ependyma of adult mice infused with
CNTF (Shimazaki et al., 2001), whereas we derived fewer neuro-
spheres frommice treatedwithAd:LIF (our unpublished results).
Given that up to 70% of neurospheres come from type C cells
(Doetsch et al., 2002), this suggests that CNTF may increase the
number of type C cells, whereas we find that LIF decreases it. The
dose of CNTF usedmay also be an issue. For example, a high dose
of CNTF results in the promotion of neurogenesis in the hypo-
thalamus [656 ng/d (Kokoeva et al., 2005)], whereas we used a
much lower dose of LIF (60–120 ng/d). In another example, the
dose of EGF has been reported to differentially affect type C cell
phenotype (Doetsch et al., 2002). Discrepancies also exist in vitro,
because some reports indicate that CNTF or LIF do not affect
neurosphere formation (Shimazaki et al., 2001; Gregg andWeiss,
2005), whereas others find that they do (Pitman et al., 2004;
present study; our unpublished results). Nevertheless, CNTF ex-
posure for the last 4 DIV increases secondary neurosphere for-
mation (Shimazaki et al., 2001), similar to the effect of LIF
(present study). Whether LIF and CNTF have similar effects on
adult NSCs in vivo remains to be determined.
Endogenous LIFR signaling promotes themaintenance of em-
bryonic and adult NSCs in vivo and in vitro (Shimazaki et al.,
2001; Pitman et al., 2004), and intracerebroventricular injection
of anti-CNTF antibodies decreases adult neurogenesis (Emsley
and Hagg, 2003). We did not address the role of endogenous LIF
in this study, but LIF expression is generally very low under phys-
iological conditions. Thus, LIF knock-out mice display no differ-
ence in olfactory precursor cell proliferation unless injury is per-
formed, at which point LIF is required for proliferation (Bauer et
al., 2003). Interestingly, brain injuries are potent inducers of LIF
expression and also increase SVZ or hippocampal cell prolifera-
tion, suggesting that LIF may be a key signaling molecule that
triggers progenitor cell recruitment after injury. Endogenous LIF
promotes cell proliferation after spinal cord injury, which is fur-
ther potentiated by exogenous LIF treatment (Kerr and Patter-
son, 2004). We demonstrate here that exogenous LIF accelerates
SVZ regeneration when infused before AraC, possibly by pro-
moting NSC self-renewal, which suggests that LIF could be used
to stimulate brain repair after injury.
In this context, the effects of chronic versus acute LIF treat-
ment are important to consider. Indeed, chronic exposure to LIF
is not physiological, because LIF expression after injury is rapid
and transient. Our data emphasize that downregulation of LIF is
necessary to end the stimulation of NSC self-renewal and allow
the harnessing of the regenerative potential of NSCs. The tran-
sient expression of LIF observed after injury may thus trigger a
period of increasedNSC self-renewal, which likely constitutes the
first step toward regeneration. Our data also suggest a model for
the development of successful therapeutic regenerative strategies
from endogenous NSCs, whereby brain repair may be achieved
with critically timed exposure to factors that stimulate NSC self-
renewal first, followed by exposure to other factors that promote
survival, migration, and differentiation of NSC progeny.
Finally, it is interesting to note that our results are reminiscent
of LIF action onmouse ES cells, suggesting a continuum from ES
cells to adult NSCs. This view is supported by recent findings
showing thatmouse ES cells plated inminimal conditions default
to a neural fate and transform into LIF-dependent primordial
NSCs, which in turn generate FGF2-dependent definitive NSCs
(Smukler et al., 2006). In those experiments, LIF appears tomain-
tain a population of primordial NSCs in an undifferentiated state
by preventing additional neural differentiation of the ES cells
(Smukler et al., 2006). LIF-dependent, primordial NSCs similar
to those derived from ES cells have also been obtained from em-
bryonic day 5.5mouse neuroectoderm (Hitoshi et al., 2004), sug-
gesting that the continuum from ES cells to NSCs described in
Table 1. Infusion of LIF for 3 d before a 6 d AraC treatment promotes subsequent
SVZ regeneration, whereas EGF instead of LIF has no effect
LIF before AraC PBS before AraC EGF before AraC
BrdU cells 82.61 4.86* 60.0 3.77 55.83 4.10†
Ki67 cells 144.50 3.33** 119.11 5.87 109.83 8.01††
BrdU/EGFR cells 49.22 2.78* 32.67 3.57 ND
In contrast, infusion of EGF before AraC has no effect on subsequent SVZ regeneration. Cell counts were performed
3 d after AraC removal. Data aremean SEM of n 3 animals per group (3 sections analyzed per animal). ND, Not
determined. *p 0.001 and **p 0.003 compared with PBS-infused controls (Student’s t test). †p 0.294 and
††p 0.255 compared with vehicle-infused controls (data not shown, results similar to PBS-infused controls).
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vitromay also exist in vivo. Together with these studies, our data
show that LIF exerts a similar range of actions from ES cells to
adult NSCs and suggest that commonmechanisms participate in
the maintenance of these various types of stem cells.
References
Arvidsson A, Collin T, Kirik D, Kokaia Z, Lindvall O (2002) Neuronal re-
placement from endogenous precursors in the adult brain after stroke.
Nat Med 8:963–970.
Banner LR, Patterson PH (1994) Major changes in the expression of the
mRNAs for cholinergic differentiation factor/leukemia inhibitory factor
and its receptor after injury to adult peripheral nerves and ganglia. Proc
Natl Acad Sci USA 91:7109–7113.
Banner LR,Moayeri NN, Patterson PH (1997) Leukemia inhibitory factor is
expressed in astrocytes following cortical brain injury. Exp Neurol
147:1–9.
Barnabe-Heider F, Wasylnka JA, Fernandes KJ, Porsche C, Sendtner M,
KaplanDR,Miller FD (2005) Evidence that embryonic neurons regulate
the onset of cortical gliogenesis via cardiotrophin-1. Neuron 48:253–265.
Bauer S, Patterson PH (2005) The cell cycle-apoptosis connection revisited
in the adult brain. J Cell Biol 171:641–650.
Bauer S, Rasika S, Han J, Mauduit C, Raccurt M, Morel G, Jourdan F,
Benahmed M, Moyse E, Patterson PH (2003) Leukemia inhibitory fac-
tor is a key signal for injury-induced neurogenesis in the adult mouse
olfactory epithelium. J Neurosci 23:1792–1803.
Bonaguidi MA, McGuire T, HuM, Kan L, Samanta J, Kessler JA (2005) LIF
and BMP signaling generate separate and discrete types of GFAP-
expressing cells. Development 132:5503–5514.
Bonni A, Sun Y, Nadal-Vicens M, Bhatt A, Frank DA, Rozovsky I, Stahl N,
YancopoulosGD,GreenbergME (1997) Regulation of gliogenesis in the
central nervous system by the JAK-STAT signaling pathway. Science
278:477–483.
Brown JP, Couillard-Despres S, Cooper-Kuhn CM, Winkler J, Aigner L,
Kuhn HG (2003) Transient expression of doublecortin during adult
neurogenesis. J Comp Neurol 467:1–10.
Chang MY, Park CH, Son H, Lee YS, Lee SH (2004) Developmental stage-
dependent self-regulation of embryonic cortical precursor cell survival
and differentiation by leukemia inhibitory factor. Cell Death Differ
11:985–996.
Charrier C, Coronas V, Fombonne J, Roger M, Jean A, Krantic S, Moyse E
(2006) Characterization of neural stem cells in the dorsal vagal complex
of adult rat by in vivo proliferation labeling and in vitro neurosphere
assay. Neuroscience 138:5–16.
Chojnacki A, Shimazaki T, Gregg C, Weinmaster G, Weiss S (2003) Glyco-
protein 130 signaling regulates Notch1 expression and activation in the
self-renewal of mammalian forebrain neural stem cells. J Neurosci
23:1730–1741.
Corness J, Shi TJ, Xu ZQ, Brulet P, Hokfelt T (1996) Influence of leukemia
inhibitory factor on galanin/GMAP and neuropeptide Y expression in
mouse primary sensory neurons after axotomy. ExpBrainRes 112:79–88.
Doetsch F (2003) The glial identity of neural stem cells. Nat Neurosci
6:1127–1134.
Doetsch F, Garcia-Verdugo JM, Alvarez-Buylla A (1997) Cellular composi-
tion and three-dimensional organization of the subventricular germinal
zone in the adult mammalian brain. J Neurosci 17:5046–5061.
Doetsch F, Caille I, Lim DA, Garcia-Verdugo JM, Alvarez-Buylla A (1999a)
Subventricular zone astrocytes are neural stem cells in the adult mamma-
lian brain. Cell 97:703–716.
Doetsch F, Garcia-Verdugo JM,Alvarez-Buylla A (1999b) Regeneration of a
germinal layer in the adult mammalian brain. Proc Natl Acad Sci USA
96:11619–11624.
Doetsch F, Petreanu L, Caille I, Garcia-Verdugo JM, Alvarez-Buylla A (2002)
EGF converts transit-amplifying neurogenic precursors in the adult brain
into multipotent stem cells. Neuron 36:1021–1034.
Emsley JG, Hagg T (2003) Endogenous and exogenous ciliary neurotrophic
factor enhances forebrain neurogenesis in adult mice. Exp Neurol
183:298–310.
Garcia AD, Doan NB, Imura T, Bush TG, Sofroniew MV (2004) GFAP-
expressing progenitors are the principal source of constitutive neurogen-
esis in adult mouse forebrain. Nat Neurosci 7:1233–1241.
Gregg C, Weiss S (2005) CNTF/LIF/gp130 receptor complex signaling
maintains a VZ precursor differentiation gradient in the developing ven-
tral forebrain. Development 132:565–578.
Hatta T, Moriyama K, Nakashima K, Taga T, Otani H (2002) The role of
gp130 in cerebral cortical development: in vivo functional analysis in a
mouse exo utero system. J Neurosci 22:5516–5524.
He F, Ge W, Martinowich K, Becker-Catania S, Coskun V, Zhu W, Wu H,
Castro D, Guillemot F, Fan G, de Vellis J, Sun YE (2005) A positive
autoregulatory loop of Jak-STAT signaling controls the onset of astroglio-
genesis. Nat Neurosci 8:616–625.
Heinrich PC, Behrmann I, Haan S, Hermanns HM, Muller-Newen G,
Schaper F (2003) Principles of interleukin (IL)-6-type cytokine signal-
ling and its regulation. Biochem J 374:1–20.
Hitoshi S, Seaberg RM,Koscik C, Alexson T, Kusunoki S, Kanazawa I, Tsuji S,
van der KooyD (2004) Primitive neural stem cells from themammalian
epiblast differentiate to definitive neural stem cells under the control of
Notch signaling. Genes Dev 18:1806–1811.
Holmberg KH, Patterson PH (2006) Leukemia inhibitory factor is a key
regulator of astrocytic, microglial and neuronal responses in a low-dose
pilocarpine injury model. Brain Res 1075:26–35.
Jankowsky JL, Patterson PH (1999) Differential regulation of cytokine ex-
pression following pilocarpine-induced seizure. Exp Neurol
159:333–346.
Kerr BJ, Patterson PH (2004) Potent pro-inflammatory actions of leukemia
inhibitory factor in the spinal cord of the adult mouse. Exp Neurol
188:391–407.
Kerr BJ, Patterson PH (2005) Leukemia inhibitory factor promotes oligo-
dendrocyte survival after spinal cord injury. Glia 51:73–79.
Kokoeva MV, Yin H, Flier JS (2005) Neurogenesis in the hypothalamus of
adult mice: potential role in energy balance. Science 310:679–683.
Lim DA, Tramontin AD, Trevejo JM, Herrera DG, Garcia-Verdugo JM,
Alvarez-Buylla A (2000) Noggin antagonizes BMP signaling to create a
niche for adult neurogenesis. Neuron 28:713–726.
Magavi SS, Leavitt BR, Macklis JD (2000) Induction of neurogenesis in the
neocortex of adult mice. Nature 405:951–955.
Maslov AY, Barone TA, Plunkett RJ, Pruitt SC (2004) Neural stem cell de-
tection, characterization, and age-related changes in the subventricular
zone of mice. J Neurosci 24:1726–1733.
Menn B, Garcia-Verdugo JM, Yaschine C, Gonzalez-Perez O, Rowitch D,
Alvarez-Buylla A (2006) Origin of oligodendrocytes in the subventricu-
lar zone of the adult brain. J Neurosci 26:7907–7918.
Minami M, Maekawa K, Yamakuni H, Katayama T, Nakamura J, Satoh M
(2002) Kainic acid induces leukemia inhibitory factor mRNA expression
in the rat brain: differences in the time course of mRNA expression be-
tween the dentate gyrus and hippocampal CA1/CA3 subfields. Brain Res
Mol Brain Res 107:39–46.
Molne M, Studer L, Tabar V, Ting YT, Eiden MV, McKay RD (2000) Early
cortical precursors do not undergo LIF-mediated astrocytic differentia-
tion. J Neurosci Res 59:301–311.
Morshead CM, Reynolds BA, Craig CG,McBurneyMW, StainesWA,Moras-
sutti D, Weiss S, van der Kooy D (1994) Neural stem cells in the adult
mammalian forebrain: a relatively quiescent subpopulation of sub-
ependymal cells. Neuron 13:1071–1082.
Morshead CM, Craig CG, van der Kooy D (1998) In vivo clonal analyses
reveal the properties of endogenous neural stem cell proliferation in the
adult mammalian forebrain. Development 125:2251–2261.
Nakatomi H, Kuriu T, Okabe S, Yamamoto S, Hatano O, Kawahara N,
Tamura A, Kirino T, NakafukuM (2002) Regeneration of hippocampal
pyramidal neurons after ischemic brain injury by recruitment of endog-
enous neural progenitors. Cell 110:429–441.
Parras CM, Galli R, Britz O, Soares S, Galichet C, Battiste J, Johnson JE,
Nakafuku M, Vescovi A, Guillemot F (2004) Mash1 specifies neurons
and oligodendrocytes in the postnatal brain. EMBO J 23:4495–4505.
PitmanM, Emery B, BinderM,Wang S, Butzkueven H, Kilpatrick TJ (2004)
LIF receptor signaling modulates neural stem cell renewal. Mol Cell Neu-
rosci 27:255–266.
Rao MS, Sun Y, Escary JL, Perreau J, Tresser S, Patterson PH, Zigmond RE,
Brulet P, Landis SC (1993) Leukemia inhibitory factor mediates an in-
jury response but not a target-directed developmental transmitter switch
in sympathetic neurons. Neuron 11:1175–1185.
Shimazaki T, Shingo T, Weiss S (2001) The ciliary neurotrophic factor/leuke-
mia inhibitory factor/gp130 receptor complexoperates in themaintenanceof
mammalian forebrain neural stem cells. J Neurosci 21:7642–7653.
12098 • J. Neurosci., November 15, 2006 • 26(46):12089–12099 Bauer and Patterson • LIF Stimulates NSC Self-Renewal In Vivo
Smukler SR, Runciman SB, Xu S, van der Kooy D (2006) Embryonic stem
cells assume a primitive neural stem cell fate in the absence of extrinsic
influences. J Cell Biol 172:79–90.
Sriram K, Benkovic SA, Hebert MA, Miller DB, O’Callaghan JP (2004) Induc-
tion of gp130-related cytokines and activation of JAK2/STAT3 pathway in
astrocytes precedes up-regulation of glial fibrillary acidic protein in the
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridinemodel ofneurodegeneration:
key signalingpathway for astrogliosis in vivo? J BiolChem279:19936–19947.
Sugiura S, Lahav R, Han J, Kou SY, Banner LR, de Pablo F, Patterson PH
(2000) Leukaemia inhibitory factor is required for normal inflammatory
responses to injury in the peripheral and central nervous systems in vivo
and is chemotactic for macrophages in vitro. Eur J Neurosci 12:457–466.
Sun Y, Zigmond RE (1996) Leukaemia inhibitory factor induced in the sci-
atic nerve after axotomy is involved in the induction of galanin in sensory
neurons. Eur J Neurosci 8:2213–2220.
Suzuki S, Tanaka K, Nogawa S, Ito D, Dembo T, Kosakai A, Fukuuchi Y
(2000) Immunohistochemical detection of leukemia inhibitory factor af-
ter focal cerebral ischemia in rats. J Cereb Blood FlowMetab 20:661–668.
Viti J, Feathers A, Phillips J, Lillien L (2003) Epidermal growth factor recep-
tors control competence to interpret leukemia inhibitory factor as an
astrocyte inducer in developing cortex. J Neurosci 23:3385–3393.
Williams RL, Hilton DJ, Pease S, Willson TA, Stewart CL, Gearing DP, Wag-
ner EF, Metcalf D, Nicola NA, Gough NM (1988) Myeloid leukaemia
inhibitory factor maintains the developmental potential of embryonic
stem cells. Nature 336:684–687.
Wright LS, Li J, Caldwell MA, Wallace K, Johnson JA, Svendsen CN (2003)
Gene expression in human neural stem cells: effects of leukemia inhibi-
tory factor. J Neurochem 86:179–195.
ZhuM,Oishi K, Lee SC, Patterson PH (2001) Studies using leukemia inhib-
itory factor (LIF) knockoutmice and a LIF adenoviral vector demonstrate
a key anti-inflammatory role for this cytokine in cutaneous inflammation.
J Immunol 166:2049–2054.
Bauer and Patterson • LIF Stimulates NSC Self-Renewal In Vivo J. Neurosci., November 15, 2006 • 26(46):12089–12099 • 12099
